Where There’s a Will, There’s a Way

With less than a month to go until the SGX lists its new India derivative products, anything can happen. All eyes are on India’s regulator, Sebi, as well as the country’s three exchanges, to see what action—if any at all—they will take.

battle chess

It just goes to show that if you’re determined enough, you will get your way. The case in point being the Singapore Exchange (SGX), which earlier in February this year was told that its data licenses with the National Stock Exchange of India (NSE) will no longer be available come August.

The NSE’s move, driven by its market regulator, the Securities and Exchange Board of India (Sebi), although sudden, was not altogether a big shock. Some market participants say that this could have been India’s

Only users who have a paid subscription or are part of a corporate subscription are able to print or copy content.

To access these options, along with all other subscription benefits, please contact info@waterstechnology.com or view our subscription options here: http://subscriptions.waterstechnology.com/subscribe

You are currently unable to copy this content. Please contact info@waterstechnology.com to find out more.

Sorry, our subscription options are not loading right now

Please try again later. Get in touch with our customer services team if this issue persists.

New to Waterstechnology? View our subscription options

FCA declines to directly regulate market data prices

A year-long investigation by the UK regulator to determine whether competition is hindered in the wholesale data markets has concluded with its decision not to directly regulate much-maligned data pricing and licensing structures.

How GenAI could improve T+1 settlement

As well as reducing settlement failures, researchers believe generative AI can provide investment managers with improved research, prioritization, and allocation resources.

You need to sign in to use this feature. If you don’t have a WatersTechnology account, please register for a trial.

Sign in
You are currently on corporate access.

To use this feature you will need an individual account. If you have one already please sign in.

Sign in.

Alternatively you can request an individual account here